|
gptkbp:instanceOf
|
angiotensin II receptor blocker
antihypertensive drug
|
|
gptkbp:approvedBy
|
2002
|
|
gptkbp:ATCCode
|
gptkb:C09CA08
|
|
gptkbp:bioavailability
|
26%
|
|
gptkbp:brand
|
gptkb:Benicar
gptkb:Olmetec
gptkb:Votum
Olmax
Olmecip
Olsar
|
|
gptkbp:CASNumber
|
gptkb:144689-63-4
|
|
gptkbp:combines
|
gptkb:amlodipine
gptkb:hydrochlorothiazide
|
|
gptkbp:contraindication
|
pregnancy
bilateral renal artery stenosis
|
|
gptkbp:developedBy
|
gptkb:Daiichi_Sankyo
|
|
gptkbp:drugClass
|
gptkb:ARB
|
|
gptkbp:eliminationHalfLife
|
13 hours
|
|
gptkbp:excretion
|
urine
feces
|
|
gptkbp:hasMolecularFormula
|
C24H26N6O3
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Olmesartan
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:marketedAs
|
gptkb:Benicar
|
|
gptkbp:mechanismOfAction
|
blocks angiotensin II type 1 receptor
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:pregnancyCategory
|
D (US)
|
|
gptkbp:proteinBinding
|
99%
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
diarrhea
dizziness
headache
hyperkalemia
|
|
gptkbp:usedFor
|
treatment of hypertension
|
|
gptkbp:bfsParent
|
gptkb:Daiichi_Sankyo
|
|
gptkbp:bfsLayer
|
6
|